Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HOXA2 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
mRNA | SLC35F6 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
mRNA | OVCA2 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
mRNA | RP11-458D21.5 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |
mRNA | ATP2B2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
mRNA | LATS1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
mRNA | MYRIP | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
mRNA | MRPS24 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
mRNA | ZBTB6 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
mRNA | NPBWR1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |